PitchBook-2025年三季度医疗技术公共报表和估值指南（英）-2025
EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research
报告摘要
EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research
核心要点
- 1 week
- 30 days
- 90 days
报告信息
- 文件全名
- 《PitchBook-2025年三季度医疗技术公共报表和估值指南（英）-2025-6页.pdf》
- 适合读者
- 核心数据
- broader markets in Q3 2025. The S&P 500 and Nasdaq gained 7.4% and 11.1%, respectively, as investors rallied around optimism
- were Tempus AI (up 36.4%) and Johnson & Johnson (up 19.2%), while Baxter and Kenvue both declined over 20% in the quarter.
- among the 13 largest medtech firms rising about 11%. Growth was led by Boston Scientific—a top acquirer over the past two
- for revenue growth to moderate closer to the 6% to 7% range in 2025 and 2026. Meanwhile, after a tough post-pandemic period,
- the life sciences sector is expected to rebound to roughly 6% growth next year, as large firms have rightsized operations and
- 核心议题
常见问题
《PitchBook-2025年三季度医疗技术公共报表和估值指南（英）-2025》主要包含哪些内容?
EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research核心数据:broader markets in Q3 2025. The S&P 500 and Nasdaq gained 7.4% and 11.1%, respectively, as investors rallied around optimism;were Tempus AI (up 36.4%) and Johnson & Johnson (up 19.2%), while Baxter and Kenvue both declined over 20% in the quarter.;among the 13 largest medtech firms rising about 11%. Growth was led by Boston Scientific—a top acquirer over the past two。
这份报告由哪家机构发布?
本报告由PitchBook发布,发布于 2025 年。
这份报告覆盖哪一年、篇幅多大?
覆盖 2025 年,全文共 6 页。
这份报告是免费的吗?如何获取?
本报告免费查阅,登录资料宝后即可在线获取完整内容。
这份报告适合哪些读者?
适合战略规划、行业研究员等读者参考。
报告涉及哪些关键议题?
重点分析了医疗等议题。
继续阅读
查看全部 →